Eszopiclone Tablets

₹ 110 / Strip

Packaging TypeYellowish
MetabolismLiver oxidation and demethylation (CYP3A4 and CYP2E1-mediated)
Elimination half-life6 hours
CAS ID138729-47-2
Supply TypeManufacturer, Exporter, Supplier, Retailer
Preferred Buyer Location India, United Kingdom, United States

Company Information

4.0/5

Member Since 5 Years
Nature of Business Trader
Year of Establishment 2011

Ask for more detail from the seller

Report incorrect details

Product Details
Company Details

Packaging TypeYellowish
Elimination half-life6 hours
FormulaC17H17ClN6O3
Trade nameLunesta, Eszop, others
CAS ID138729-47-2
Molar mass388.808 g/mol
MetabolismLiver oxidation and demethylation (CYP3A4 and CYP2E1-mediated)

eszopiclone, sold under the brand-name lunesta among others, is a medication used in the treatment of insomnia. Evidence supports some benefit up to six months. The degree of effectiveness is slight to moderate. It is taken by mouth. Common side effects include headache, dry mouth, nausea, and dizziness